Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-25Field Evaluation of a Point-of-care Triage Test for Active Tuberculosis
-
CLINICAL_TRIALS study record update · 2022-01-25A Phase 2 Trial to Evaluate the Early Bactericidal Activity and Safety of Meropenem With Amoxicillin/Clavulanate Plus Either Pyrazinamde or Bedaquiline in Adults With Newly Diagnosed Rifampicin-susceptible Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2022-01-25A Phase II Trial to Describe the Pharmacokinetics, Safety and Efficacy of Pharmacogenetics-guided Dosing of Isoniazid in Patients With HIV-associated TB
-
CLINICAL_TRIALS study record update · 2022-01-21Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes: a RCT
-
CLINICAL_TRIALS study record update · 2022-01-21The Effect of Telephone Follow-up and Training on Treatment Adherence in Tuberculosis Patients and Contacts: A Randomised, Controlled and Quasi Experimental Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-18Diagnosis of Tuberculosis Infection in HIV Co-infected Children
-
CLINICAL_TRIALS study record update · 2022-01-18The Utility of Interferon-Gamma Release Assays in TB-HIV Co-infected Children
-
CLINICAL_TRIALS study record update · 2021-12-20Evaluation of the Catalyzing Pediatric TB Innovations Project: A Pre- and Post-Implementation Assessment Across Ten Countries
-
CLINICAL_TRIALS study record update · 2021-12-13Comparing the Accessibility of the World Health Organization's Tuberculosis Guidelines to the eTB Catalogue of Recommendations: A Two-Arm Superiority Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-11-30An Open-Label, Phase II Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy
-
CLINICAL_TRIALS study record update · 2021-11-23Mansonella Perstans Effects on BCG Vaccine-induced Protection Against Childhood Tuberculosis (TB) as Well as TB Disease Severity and Recovery in Cameroon (MAP-TB)
-
CLINICAL_TRIALS study record update · 2021-11-11A Phase 2, Multi-center, Non-controlled, Open-label Dose Escalation Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Orally Administered OPC-67683 Two Times Daily to Patients With Pulmonary Multidrug-Resistant Tuberculosis Refractory to Conventional Treatment
-
CLINICAL_TRIALS study record update · 2021-11-10Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2021-11-05A Phase I, Three-Arm Safety, Tolerability, and Pharmacokinetic Interaction Study of PA-824, an Investigational Nitroimidazole for the Treatment of Tuberculosis, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
-
CLINICAL_TRIALS study record update · 2021-11-05Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-11-04The Treatment of Pulmonary Mycobacterium Tuberculosis in HIV Infection
-
CLINICAL_TRIALS study record update · 2021-11-04Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
-
CLINICAL_TRIALS study record update · 2021-11-03A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
-
CLINICAL_TRIALS study record update · 2021-11-02Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
-
CLINICAL_TRIALS study record update · 2021-11-02Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
-
CLINICAL_TRIALS study record update · 2021-11-01A Phase I, Safety, Tolerability, and Pharmacokinetic Interaction Study of Single-Dose TMC207 and Efavirenz in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-11-01Safety, Tolerability, and Pharmacokinetic Interactions of Atazanavir and Rifampin in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-11-01Phase 1, Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
-
CLINICAL_TRIALS study record update · 2021-11-01Dose-Finding and Pharmacogenetic Study of Efavirenz in HIV-infected and HIV/TB Co-infected Infants and Children 3 Months to Less Than 36 Months of Age
-
CLINICAL_TRIALS study record update · 2021-10-29Effect of Active Hexose Correlated Compound to Clinical and Immunological Response in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection